Figure 6.
Proposed model in which higher peritransplantation alemtuzumab levels drive T-cell depletion of the stem cell graft, inhibit graft-versus-marrow effect, and facilitate secondary GF after RIC HCT.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.